Biomapas Logo
cropped-favicon-biomapas.png

Different Affiliate Based Outsourcing Models for Regulatory Affairs

Different Affiliate Based Outsourcing Models for Regulatory Affairs

Webinar: Different Affiliate-Based Outsourcing Models for Regulatory Affairs

Often questions arise about the Affiliate-Based Outsourcing (ABO) Models for Regulatory Affairs:
1. How can it fit your specific needs?
2. How can it adapt to your organization and setup?
3. What are its possibilities of adjusting to your portfolio?

The purpose of this webinar is to share insights on the Regulatory Affairs Affiliate-Based Outsourcing Model’s flexibility and practical tips on how it can be tailored to your needs. We will share examples of different scenarios on how the ABO model can be customized to optimize costs and efficiently manage your local regulatory operations.

 

Expanding across Europe?

Make use of our experience. Explore your options in an informal chat with one of our experts.

This webinar focuses on learning:

  1. What are the options for the Affiliate-Based Outsourcing Model for Regulatory Affairs.
  2. What are the benefits of different models.
  3. What are the common challenges and how to overcome them.
  4. How to select the most beneficial Affiliate-Based Outsourcing Model for you.

Duration: 30 minutes

Speaker: Head of Regulatory Affairs, Olga Bernardova.

Olga Bernardova

Olga Bernardova

Head of Regulatory Affairs

Other content that might interest you:

Download – ABO Whitepaper

Download – ABO Whitepaper

Whitepaper Regulatory Affairs Outsourcing Affiliate-Based Outsourcing for Regulatory Affairs acts as an addition or replacement of your in-house local regulatory capabilities. However, it frequently falls short of meeting the requirements for effective organization,...

read more
What is the Clinical Trials Regulation?

What is the Clinical Trials Regulation?

The EU CTR is the new Regulation that govers all interventional clinical trials using human medicinal products. By implementing this Clinical Trials Regulation (CTR) early 2022, the European Commission hopes to establish a better environment for clinical trials in the...

read more
Marketing Authorization Process in Russia

Marketing Authorization Process in Russia

Cultural and language problems are a frequent stumbling block for multinational corporations seeking to register drugs in Russia. Additionally, the Marketing Authorization process in Russia is highly complex, and the paperwork frequently changes as the regulatory...

read more
Drug Registration in Russia

Drug Registration in Russia

 Overview of drug registration in Russia The Russian pharmaceutical industry is expected to exceed two trillion Russian rubles in 2020, representing a roughly 10% growth over the previous year. Pharmaceutical revenues are expected to reach 2.35 trillion Russian rubles...

Drug Registration in the Eurasian Economic Union (EAEU)

Drug Registration in the Eurasian Economic Union (EAEU)

If you are interested in marketing your medicinal product in the fast-growing pharmaceutical market of the Eurasian Economic Union (EAEU) and if you want to how to apply for market authorization in the EAEU, this blog post is for you. The first part of this article...

Marketing Authorization Renewal in the MENA Region

Marketing Authorization Renewal in the MENA Region

Regulatory Authorities across the MENA region indicate a specific validity period for the Marketing Authorization Approval certificate of pharmaceutical products that ranges between four to five years in most countries. The purpose behind this license validity period...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information